BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 24473924)

  • 1. Increased risk of malignant melanoma in patients with systemic mastocytosis?
    Hägglund H; Sander B; Gülen T; Lindelöf B; Nilsson G
    Acta Derm Venereol; 2014 Sep; 94(5):583-4. PubMed ID: 24473924
    [No Abstract]   [Full Text] [Related]  

  • 2. Melanoma and mastocytosis: is really only a coincidence?
    Capo A; Goteri G; Mozzicafreddo G; Serresi S; Giacchetti A
    Clin Exp Dermatol; 2019 Jan; 44(1):76-77. PubMed ID: 30178486
    [No Abstract]   [Full Text] [Related]  

  • 3. [Urticaria pigmentosa/systemic mastocytosis].
    Moretti D; Kilstein J; Zicre D; Bagilet DH
    Med Clin (Barc); 2011 Apr; 136(12):558. PubMed ID: 20149398
    [No Abstract]   [Full Text] [Related]  

  • 4. Malignant melanoma and systemic mastocytosis--a possible association?
    Todd P; Garioch J; Seywright M; Rademaker M; Thomson J
    Clin Exp Dermatol; 1991 Nov; 16(6):455-7. PubMed ID: 1806323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response of urticaria pigmentosa to cladribine in a patient with systemic mastocytosis.
    Bennett M; Chubar Y
    Br J Haematol; 2013 Feb; 160(4):420. PubMed ID: 23205635
    [No Abstract]   [Full Text] [Related]  

  • 6. Telangiectasia macularis eruptiva perstans, a form of cutaneous mastocytosis, associated with malignant melanoma.
    Kowalzic L; Eickenscheidt L; Seidel C; Kribus S; Ziegler H; Komar M
    J Dtsch Dermatol Ges; 2009 Apr; 7(4):360-2. PubMed ID: 19054427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of highly sensitive diagnostic methods to the diagnosis of systemic mastocytosis in the absence of skin lesions.
    Alvarez-Twose I; Matito A; Sánchez-Muñoz L; Morgado JM; Orfao A; Escribano L; van Doormaal JJ; van der Veer E; van Voorst Vader PC; Kluin PM; Mulder AB; van der Heide S; Arends S; Kluin-Nelemans JC; Oude Elberink JN; de Monchy JG
    Allergy; 2012 Sep; 67(9):1190-1. PubMed ID: 22882359
    [No Abstract]   [Full Text] [Related]  

  • 8. CD25 expression on cutaneous mast cells from adult patients presenting with urticaria pigmentosa is predictive of systemic mastocytosis.
    Hollmann TJ; Brenn T; Hornick JL
    Am J Surg Pathol; 2008 Jan; 32(1):139-45. PubMed ID: 18162781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Gougerot-Carteaud papillomatosis complicated by diffuse mastocytosis].
    Szodoray L
    Z Haut Geschlechtskr; 1969 Jun; 44(11):Suppl:85-6. PubMed ID: 5360185
    [No Abstract]   [Full Text] [Related]  

  • 10. Tryptase and histamine metabolites as diagnostic indicators of indolent systemic mastocytosis without skin lesions.
    van Doormaal JJ; van der Veer E; van Voorst Vader PC; Kluin PM; Mulder AB; van der Heide S; Arends S; Kluin-Nelemans JC; Oude Elberink JN; de Monchy JG
    Allergy; 2012 May; 67(5):683-90. PubMed ID: 22435702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Multiple fibromas in systemic mastocytosis].
    Klepper L; Tronnier M
    J Dtsch Dermatol Ges; 2005 May; 3(5):363-5. PubMed ID: 16372804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic mastocytosis: a potential neurologic emergency.
    Boncoraglio GB; Brucato A; Carriero MR; Maccagnano E; Robbiolo L; Scappatura LO; Soligo D; Parati EA
    Neurology; 2005 Jul; 65(2):332-3. PubMed ID: 16043817
    [No Abstract]   [Full Text] [Related]  

  • 13. Systemic mastocytosis associated with cutaneous B-cell lymphoma.
    Meyer KM; Landthaler M; Hafner C; Geissinger E
    Br J Dermatol; 2013 Nov; 169(5):1165-7. PubMed ID: 23773144
    [No Abstract]   [Full Text] [Related]  

  • 14. Gastrointestinal manifestations of dermatologic disorders.
    Shields HM; Shaffer K; O'farrell RP; Travers R; Hayward JN; Becker LS; Lauwers GY
    Clin Gastroenterol Hepatol; 2007 Sep; 5(9):1010-7; quiz 1005-6. PubMed ID: 17825768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A further case of generalized muscular nevus with a "Michelin baby" clinical aspect associated with cutaneous mastocytosis].
    Patrizi A; Neri I; Varotti C
    Ann Dermatol Venereol; 1989; 116(8):551-4. PubMed ID: 2596798
    [No Abstract]   [Full Text] [Related]  

  • 16. Unusual cutaneous findings of urticaria pigmentosa and telangiectasia macularis eruptiva perstans associated with marked myelofibrosis.
    Turchin I; Barankin B; Schloss E
    Int J Dermatol; 2006 Oct; 45(10):1215-7. PubMed ID: 17040445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent syncope and anaphylaxis as presentation of systemic mastocytosis in a pediatric patient: case report and literature review.
    Shaffer HC; Parsons DJ; Peden DB; Morrell D
    J Am Acad Dermatol; 2006 May; 54(5 Suppl):S210-3. PubMed ID: 16631942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Basophil/mast cell precursors in mast cell proliferative disorders.
    Denburg JA; Telizyn S; Ahlstedt S; Olafsson JH; Roupe G; Bienenstock J
    Clin Invest Med; 1986; 9(1):21-5. PubMed ID: 3955917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sudden death in the presence of systemic mastocytosis and urticaria pigmentosa].
    Wehner F; Wehner HD; Fritz P; Benz D; Schulz MM
    Arch Kriminol; 2008; 222(5-6):187-94. PubMed ID: 19216369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mastocytosis. Main symptoms of cutaneous mastocytosis: urticaria pigmentosa].
    Kolyvanos Naumann U; Käser L; Vetter W
    Praxis (Bern 1994); 2005 Sep; 94(36):1373-9; quiz 1380. PubMed ID: 16190370
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.